Defense Proteins: Exposing the invader
The immune system is a large network of organs, cells and molecules that work together to protect the body from disease-causing pathogens. It consists of an innate immune response (which activates macrophages and dendritic cells) and an adaptive immune response (which activates T cells and B cells).
Most cells in the body also have an intrinsic response against viruses, in which they express proteins that can detect the invading virus and block its replication. From the initial entry into a cell, through to the budding and release of new virus particles, intrinsic anti-viral factors can detect a broad range of viral molecules, including the RNA or DNA of the virus. In response, cells produce signaling proteins, such as interferons, to stimulate anti-viral defenses in neighboring cells and to target viral infections at various stages of their lifecycle.
For example, the restriction factor myxovirus resistance protein B (MxB) is activated by interferons, and has been shown to inhibit the replication of a broad range of viruses, including HIV and herpesviruses (Liu et al., 2013; Matreyek et al., 2014; Crameri et al., 2018; Schilling et al., 2018). However, its mechanism of action is poorly understood (Wilbourne and Zhang, 2021; Xie et al., 2021). Now, in eLife, Beate Sodeik and colleagues – including Manutea Serrero from Hanover Medical School as first author – report new insights into the interactions between MxB and herpesviruses (Serrero et al., 2022).
All herpesviruses consist of a capsid protein that surrounds their DNA, and a layer called the tegument that links the capsid with the membrane envelope engulfing the virus particle (Figure 1A; Dai and Zhou, 2018; Huet et al., 2016). Upon infection, the viral envelope fuses with the membrane of the host cell and releases the capsid and most of the tegument layer into the cell. These are then transported to the nucleus, where they can hijack the replication machinery of the host cell (Figure 1B).
To find out how anti-viral proteins inhibit the replication of herpes simplex virus, Serrero et al. used cell-free methods to reconstitute the complexes typically formed by these proteins and viral particles. To do so, they prepared protein extracts from ‘naïve’ macrophages and macrophages that had been exposed to an interferon, as these cells are known to mount a robust interferon response. These were then mixed with either capsids from extracellular viral particles containing varying amounts of tegument proteins, or tegument-free capsids from the nuclei of infected cells. The resulting complexes were characterized using quantitative mass spectrometry. This revealed MxB as one of the molecules interacting with the capsid, with a particular affinity for capsids lacking the tegument layer.
To test if MxB could also affect the stability of the capsid, the team (who are based at various institutes in Germany, the United States and the United Kingdom) bound the virus capsids onto electron microscopy grids and incubated them with cellular fluids extracted from naïve macrophages or macrophages that had been exposed to interferons. Electron microscopy revealed that capsids treated with the interferon-stimulated cell extracts were significantly more damaged and impaired compared to the capsids exposed to untreated cell extracts.
Moreover, further experiments using host cells from genetically modified lung tissue lacking MxB showed that extracts from these cells did not damage the capsid, highlighting its importance in capsid breakdown. In particular, MxB may attach to connector proteins (pUL17, pUL25, pUL36) that normally link the tegument and the capsid (Figure 1A). Furthermore, Serrero et al. found that when MxB was added to extracts from naïve cells that had not been activated by interferons, this caused the capsids to breakdown.
Perhaps the most intriguing result is that MxB works most efficiently on capsids lacking the tegument layer. In fact, MxB was unable to bind to capsids and destroy them when tegument proteins remained associated with the capsid. This suggests that tegument proteins shield the capsids from immune factors such as MxB, potentially by blocking their interaction with the connector proteins pUL17, pUL25 and pUL36.
The study of Serrero et al. further suggests that there is a fine balance within cells where loss of tegument proteins determines when capsids can be targeted by anti-viral factors, such as MxB. The binding of MxB to the tegument-free capsid and its partial destruction may in turn affect how new virus particles target the host cell’s nuclei. This could potentially disrupt the assembly of future capsids formed during viral replication, as MxB might engage with virions as they mature in the nucleus. In addition, the release of viral genomes from the damaged capsids may enhance the activation of defense proteins sensing the foreign particle, thereby amplifying the intrinsic immune responses of the host cell.
Since these experiments were done using cell-free assays, it remains to be seen whether MxB induces the breakdown of viral capsids in infected cells. A better understanding of how the tegument can shield the capsids from MxB could pave the way for new treatments against herpesviruses and other viral invaders.
References
-
MxB is an interferon-induced restriction factor of human herpesvirusesNature Communications 9:1980.https://doi.org/10.1038/s41467-018-04379-2
-
Extensive subunit contacts underpin herpesvirus capsid stability and interior-to-exterior allosteryNature Structural & Molecular Biology 23:531–539.https://doi.org/10.1038/nsmb.3212
-
The interferon-inducible MxB protein inhibits HIV-1 infectionCell Host & Microbe 14:398–410.https://doi.org/10.1016/j.chom.2013.08.015
-
Human MxB protein is a pan-herpesvirus restriction factorJournal of Virology 92:e01056-18.https://doi.org/10.1128/JVI.01056-18
Article and author information
Author details
Publication history
Copyright
© 2022, Bayer and Homa
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,179
- views
-
- 84
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Immunology and Inflammation
Airway macrophages (AM) are the predominant immune cell in the lung and play a crucial role in preventing infection, making them a target for host directed therapy. Macrophage effector functions are associated with cellular metabolism. A knowledge gap remains in understanding metabolic reprogramming and functional plasticity of distinct human macrophage subpopulations, especially in lung resident AM. We examined tissue-resident AM and monocyte-derived macrophages (MDM; as a model of blood derived macrophages) in their resting state and after priming with IFN-γ or IL-4 to model the Th1/Th2 axis in the lung. Human macrophages, regardless of origin, had a strong induction of glycolysis in response to IFN-γ or upon stimulation. IFN-γ significantly enhanced cellular energetics in both AM and MDM by upregulating both glycolysis and oxidative phosphorylation. Upon stimulation, AM do not decrease oxidative phosphorylation unlike MDM which shift to ‘Warburg’-like metabolism. IFN-γ priming promoted cytokine secretion in AM. Blocking glycolysis with 2-deoxyglucose significantly reduced IFN-γ driven cytokine production in AM, indicating that IFN-γ induces functional plasticity in human AM, which is mechanistically mediated by glycolysis. Directly comparing responses between macrophages, AM were more responsive to IFN-γ priming and dependent on glycolysis for cytokine secretion than MDM. Interestingly, TNF production was under the control of glycolysis in AM and not in MDM. MDM exhibited glycolysis-dependent upregulation of HLA-DR and CD40, whereas IFN-γ upregulated HLA-DR and CD40 on AM independently of glycolysis. These data indicate that human AM are functionally plastic and respond to IFN-γ in a manner distinct from MDM. These data provide evidence that human AM are a tractable target for inhalable immunomodulatory therapies for respiratory diseases.
-
- Immunology and Inflammation
Adipose tissue inflammation is now considered to be a key process underlying metabolic diseases in obese individuals. However, it remains unclear how adipose inflammation is initiated and maintained or the mechanism by which inflammation develops. We found that microRNA-802 (Mir802) expression in adipose tissue is progressively increased with the development of dietary obesity in obese mice and humans. The increasing trend of Mir802 preceded the accumulation of macrophages. Adipose tissue-specific knockout of Mir802 lowered macrophage infiltration and ameliorated systemic insulin resistance. Conversely, the specific overexpression of Mir802 in adipose tissue aggravated adipose inflammation in mice fed a high-fat diet. Mechanistically, Mir802 activates noncanonical and canonical NF-κB pathways by targeting its negative regulator, TRAF3. Next, NF-κB orchestrated the expression of chemokines and SREBP1, leading to strong recruitment and M1-like polarization of macrophages. Our findings indicate that Mir802 endows adipose tissue with the ability to recruit and polarize macrophages, which underscores Mir802 as an innovative and attractive candidate for miRNA-based immune therapy for adipose inflammation.